Skip to main content
OXFORD BIODYNAMICS PLC logo

OXFORD BIODYNAMICS PLC — Investor Relations & Filings

Ticker · OBD ISIN · GB00BD5H8572 LEI · 2138005Y1TK258O5U928 IL Professional, scientific and technical activities
Filings indexed 416 across all filing types
Latest filing 2017-05-19 Regulatory Filings
Country GB United Kingdom
Listing IL OBD

About OXFORD BIODYNAMICS PLC

https://www.oxfordbiodynamics.com/

Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests. The company's proprietary EpiSwitch® platform utilizes 3D genomics and epigenetic biomarkers to create diagnostic solutions for life-changing diseases, with a focus on oncology. Its portfolio of clinical tests includes the EpiSwitch® PSE, a blood test that assesses the likelihood of prostate cancer with high accuracy to help reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test designed to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. The platform enables the translation of 3D genome regulation into clinical applications for precision medicine at scale.

Recent filings

Filing Released Lang Actions
Appointment of Shore Capital as Joint Broker
Regulatory Filings Classification · 98% confidence The document is very short (2882 characters) and contains an 'RNS Number' header, indicating it is a regulatory announcement from the London Stock Exchange's news service. The content announces the 'Appointment of Shore Capital as Joint Broker' and provides contact details. This type of corporate action announcement, which is not a financial report (like 10-K or IR) or a specific event material (like AGM or CT), fits best under the general regulatory announcement category, RNS, as it is a miscellaneous, mandatory disclosure.
2017-05-19 English
Subsidiary signs exclusive Asia licence
Environmental & Social Information Classification · 99% confidence The document begins with an 'RNS Number' and the date, followed by an announcement from Oxford BioDynamics Plc regarding a subsidiary signing an exclusive Asia licence agreement for its EpiSwitch™ technology. The content details a commercial transaction (licensing, royalties, milestones) and includes quotes from management. The presence of 'RNS Number' and the nature of the announcement (a significant commercial/operational update) strongly suggest this is a regulatory news service announcement. Since it is not a full financial report (10-K, IR), a specific management change (MANG), or a dividend notice (DIV), the most appropriate general category for a standard regulatory news release is RNS, which serves as the fallback for miscellaneous regulatory announcements.
2017-05-18 English
Representation on NIH steering committees
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and the date, which strongly suggests a regulatory announcement made via the London Stock Exchange's Regulatory News Service (RNS). The content describes an announcement regarding a member of the Scientific Advisory Panel joining prestigious external committees (FNIH Biomarkers Consortium Steering Committees). This is an announcement of corporate/personnel news that is material to investors but does not fit the specific definitions for earnings (ER), capital changes (CAP), director dealings (DIRS), or formal reports (10-K, IR). Since it is a general regulatory announcement distributed via RNS and doesn't fit a more specific category, the most appropriate classification is the general regulatory filing category.
2017-04-20 English
BIO-FLARE Collaboration
Legal Proceedings Report Classification · 99% confidence The document begins with 'RNS Number : 7824Z' and is dated March 17, 2017. It announces a collaboration and funding award related to Rheumatoid Arthritis research. The presence of the RNS number and the nature of the announcement (a corporate update that is not a primary financial report like 10-K or IR, nor a specific event like AGM or Dividend) strongly suggests it is a general regulatory announcement disseminated via the London Stock Exchange's news service. Since it doesn't fit the specific categories like M&A (TAR), Capital Change (CAP), or Director Dealing (DIRS), the most appropriate fallback category for a general regulatory news service release is RNS.
2017-03-17 English
AGM Results and Related Party Transaction
AGM Information Classification · 99% confidence The document explicitly states 'Results of Annual General Meeting' and confirms that 'all resolutions as set out in the Notice of Annual General Meeting dated 31 January 2017 were duly passed by shareholders'. This directly corresponds to the definition of AGM Information (AGM-R). Although it also mentions a related party transaction, the primary announcement concerns the outcome of the AGM. The presence of the 'RNS Number' and the 'END' marker suggests it was disseminated via a regulatory news service, but the content itself is specific to the AGM results, making AGM-R the most precise classification over the general RNS fallback.
2017-03-15 English
Appointment of Martin Reeves as SVP
Board/Management Information Classification · 98% confidence The document explicitly starts with 'RNS Number : 9112Y' and ends with 'This information is provided by RNS The company news service from the London Stock Exchange END'. This clearly identifies it as a regulatory news service announcement. The content details the appointment of a new Senior Vice President, which falls under personnel/management changes. While 'Board/Management Information' (MANG) is a possibility, the format and source identifier ('RNS') strongly suggest it is a general regulatory filing announcement. Since 'RNS' is defined as the fallback for miscellaneous filings that do not fit neatly elsewhere, and this is a standard regulatory news wire release, RNS is the most appropriate classification for the *format* of the filing, even though the *content* is management-related. Given the strong RNS markers, I will classify it as RNS.
2017-03-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.